Combined quantitative tuberculosis biomarker model for time-to-positivity and colony forming unit to support tuberculosis drug development
Biomarkers are quantifiable characteristics of biological processes. In Mycobacterium tuberculosis, common biomarkers used in clinical drug development are colony forming unit (CFU) and time-to-positivity (TTP) from sputum samples. This analysis aimed to develop a combined quantitative tuberculosis...
Saved in:
Main Authors: | Rami Ayoun Alsoud (Author), Robin J. Svensson (Author), Elin M. Svensson (Author), Stephen H. Gillespie (Author), Martin J. Boeree (Author), Andreas H. Diacon (Author), Rodney Dawson (Author), Rob E. Aarnoutse (Author), Ulrika S. H. Simonsson (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2023-03-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The Population Pharmacokinetics of Meropenem in Adult Patients With Rifampicin-Sensitive Pulmonary Tuberculosis
by: Ahmed A. Abulfathi, et al.
Published: (2021) -
Power to identify exposure‐response relationships in phase IIa pulmonary tuberculosis trials with multi‐dimensional bacterial load modeling
by: Simon E. Koele, et al.
Published: (2024) -
Exposure-safety analysis of QTc interval and transaminase levels following bedaquiline administration in patients with drug‐resistant tuberculosis
by: Lénaïg Tanneau, et al.
Published: (2021) -
Standards for model-based early bactericidal activity analysis and sample size determination in tuberculosis drug development
by: Laurynas Mockeliunas, et al.
Published: (2023) -
Optimizing the design of a pharmacokinetic trial to evaluate the dosing scheme of a novel tuberculosis drug in children living with or without HIV
by: Grace Montepiedra, et al.
Published: (2024)